ATUSA 3D automated breast ultrasound for suspicious breast lesions
Official title: ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE), a Case Collection Registry for 3D Breast Automated Ultrasound Using ATUSA System as Well as Other Breast Imaging Modalities.
Run by iSono Health, Inc. · NCT07505797 · Data updated 2026-11-12
This study will test whether the ATUSA 3D automated breast ultrasound system can produce high-quality images that match biopsy results in women with BI-RADS 4 or 5 breast findings.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 94 Years |
| Sex | Women only |
| Enrollment | 800 (estimated) |
| Sponsor | iSono Health, Inc. Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 2 sites (Sacramento, California and 1 other locations) |
| Status | Recruiting |
| Started | December 16, 2025 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT07505797 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 to 94 with a recent BI-RADS 4 or 5 breast imaging result who are scheduled for biopsy and can attend imaging and follow-up visits are ideal candidates.
✕Probably not a fit
Patients who are pregnant or breastfeeding, have incompatible breast anatomy or recent breast surgery/treatment, active skin lesions, MRI-incompatible implants, or a prior bilateral mastectomy are unlikely to benefit or may be ineligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
AUDIBLE is a multi-site observational registry in the United States collecting 3D automated breast ultrasound images using the iSono Health ATUSA system from up to 800 female patients with BI-RADS 4 or 5 findings referred for biopsy. Participants will undergo ATUSA imaging in addition to their standard-of-care imaging and the study will gather multi-modality images, medical record data, and biopsy histopathology. The protocol examines image quality, reproducibility, and how ATUSA findings correlate with radiologist-assigned BI-RADS categories and histopathology, and follows a subset of patients receiving neoadjuvant therapy longitudinally. Collected data will be centralized to support device validation and a comprehensive imaging registry.
Why it matters
Potential benefit: If successful, ATUSA could provide more consistent, reproducible ultrasound images that better correspond to biopsy results and help clinicians make more accurate diagnostic decisions, especially in patients with dense breasts.
How similar studies have gone: Automated 3D breast ultrasound systems (ABUS) have shown promising results, particularly for lesion detection in dense breasts, but device-specific validation data for ATUSA remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Provide written informed consent through a signed and dated consent form. 2. Demonstrate commitment to complete all study requirements and maintain availability for the full study duration. 3. Be female, aged 18 to 94 years (inclusive). 4. Have a recent BI-RADS® 4 or 5 classification confirmed through breast imaging and medical records. Exclusion Criteria: 1. Active skin lesions (open wounds or unhealed sores) on either breast. 2. Implanted medical devices (pacemakers, defibrillators) or MRI incompatible materials that cannot be temporarily removed. 3. Current pregnancy or breastfeeding status (self-reported).Documented hypersensitivity to silicone or gadolinium-based contrast agents. 4. Previous bilateral mastectomy. 5. Physical inability to maintain a supine position for 30 minutes. 6. Breast anatomy incompatible with ATUSA device specifications. 7. Recent (within 12 months) breast surgery or cancer treatment. 8. Negative findings on diagnostic ultrasound examination within 30 days of Screening, but prior to initiating study required procedures. 9. Any medical or psychological condition that, in the Principal Investigator's judgment, could affect study participation or data integrity.
Where it's running
-
UC Davis
Sacramento, California, United States Recruiting -
Cypress Innovative Breast Care Center
Cypress, Texas, United States Recruiting
Study contacts
- Study coordinator: Neda Razavi
- Email: ATUSA@isonohealth.com
- Phone: 415-857-3073
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oncoliq blood test for early detection of breast cancer
This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.
-
UCF MammoChat mammogram image repository for AI development
This project collects donated mammogram images and questionnaire data from adults who had breast imaging to help build and test AI that could read mammograms more accurately.
-
Biennial contrast-enhanced mammography for women with a history of breast cancer
This study is testing if using a special type of mammogram every two years along with yearly 3D breast scans can help women with a history of breast cancer find any new cancers more effectively than just the yearly scans alone.
-
Understanding how tumor shrinkage predicts cancer response in early breast cancer patients
This study tests if measuring how much breast tumors shrink during chemotherapy can help predict how well the treatment will work for women with early-stage breast cancer.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
Support tool for women with HR+ breast cancer on long-term endocrine therapy
This study tests a SHIELD web- and app-based portal to help women with hormone receptor–positive breast cancer manage symptoms while on long-term endocrine treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.